0001905806-22-000001.txt : 20220121 0001905806-22-000001.hdr.sgml : 20220121 20220121105621 ACCESSION NUMBER: 0001905806-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220121 DATE AS OF CHANGE: 20220121 EFFECTIVENESS DATE: 20220121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Grannus Therapeutics Inc. CENTRAL INDEX KEY: 0001905806 IRS NUMBER: 844009398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-430313 FILM NUMBER: 22544626 BUSINESS ADDRESS: STREET 1: 7210 N. PENNSYLVANIA STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46240 BUSINESS PHONE: 3174146205 MAIL ADDRESS: STREET 1: 7210 N. PENNSYLVANIA STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46240 D 1 primary_doc.xml X0708 D LIVE 0001905806 Grannus Therapeutics Inc. 7210 N. PENNSYLVANIA STREET INDIANAPOLIS IN INDIANA 46240 3174146205 DELAWARE Grannus Therapeutics LLC None Corporation true 2020 John Foglesong 7210 N. Pennsylvania Street Indianapolis IN INDIANA 46240 Executive Officer Director Brian Blagg 7210 N. Pennsylvania Street Indianapolis IN INDIANA 46240 Director James Thompson 7210 N. Pennsylvania Street Indianapolis IN INDIANA 46240 Director Biotechnology Decline to Disclose 06b false 2022-01-12 false true false 35000 1000000 950000 50000 false 11 0 0 0 false Grannus Therapeutics Inc. John Foglesong John Foglesong CEO 2022-01-21